Table 5.
Comparison between 7-day alive and 7-day died sepsis patients’ subgroups regarding demographic data, laboratory investigations, PAI, SOFA score, MPO, and CIT-HIST-H3.
| Sepsis patient group No. = 138 |
7-day alive | 7-day died | P-value | |
|---|---|---|---|---|
| No. = 114 | No. = 24 | |||
| Age (years) | Mean ± SD | 49.63 ± 17.28 | 71.08 ± 10.26 | 0.000• |
| Range | 16–84 | 52–89 | ||
| Sex | Male | 42 (36.8%) | 8 (33.3%) | 0.818* |
| Female | 72 (63.2%) | 16 (66.7%) | ||
| HB g/dL | Mean ± SD | 9.88 ± 1.77 | 9.49 ± 2.07 | 0.505• |
| Range | 6.8–17 | 5.1–11.6 | ||
| WBCs (x103/ul) | Mean ± SD | 12.82 ± 4.89 | 14.67 ± 5.07 | 0.241• |
| Range | 5–32.8 | 3.4–22.2 | ||
| PNL (x103/ul) | Mean ± SD | 9.98 ± 4.55 | 14.59 ± 3.02 | 0.001• |
| Range | 2.02–27.54 | 10.98–20.65 | ||
| LYMP (x103/ul) | Median (IQR) | 1.16 (0.76–2) | 0.74 (0.46–1.01) | 0.020≠ |
| Range | 0.26–3.8 | 0.14–2.21 | ||
| N/L ratio | Median (IQR) | 7.3 (5.88–12) | 19.8 (13.96–30.78) | 0.000≠ |
| Range | 0.77–36.24 | 7.07–115 | ||
| PLTs (x103/ul) | Median (IQR) | 131 (80–236) | 68 (37–140) | 0.033≠ |
| Range | 2–602 | 15–220 | ||
| PT (sec) | Mean ± SD | 18.37 ± 5.77 | 28.67 ± 17.3 | 0.000• |
| Range | 12.9–44.8 | 14–70.5 | ||
| INR | Mean ± SD | 1.71 ± 0.77 | 2.44 ± 1.38 | 0.012• |
| Range | 1.13–4.62 | 1.3–5.84 | ||
| PTT (sec) | Mean ± SD | 52.89 ± 29.91 | 55.27 ± 26.49 | 0.807• |
| Range | 23.9–140 | 31.3–130 | ||
|
FDPs (< 5 Ug/ml) |
Median (IQR) | 21 (10.1–32) | 40.4 (23–52) | 0.037≠ |
| Range | 3–170 | 6.7–160 | ||
|
D dimer (0-0.55 Ug/ml) |
Median (IQR) | 2.12 (1.65–3.97) | 5 (2.44–5) | 0.011≠ |
| Range | 0.98–7 | 1.73–7 | ||
|
Fibrinogen (2–4 g/L) |
Median (IQR) | 4 (2.3–5.75) | 2 (0.9–3.5) | 0.028≠ |
| Range | 0.7–9 | 0.5–6.7 | ||
|
Procalcitonin (Up to 0.05 ng/ml) |
Median (IQR) | 7.9 (1.39–21.7) | 1.6 (0.75–2) | 0.125≠ |
| Range | 0.05–120 | 0.44–9.59 | ||
|
CRP (< 5 mg/L) |
Median (IQR) | 110 (45–246) | 46.25 (33.75–112) | 0.103≠ |
| Range | 15–396 | 24–120 | ||
| PAI (N = 5-20ng/ml) | Mean ± SD | 37.23 ± 16.41 | 72.65 ± 8.35 | 0.000• |
| Range | 15.39–71.93 | 60.56–87.64 | ||
| SOFA score | Median (IQR) | 5 (4–8) | 5 (4–9.5) | 0.847≠ |
| Range | 3–16 | 3–17 | ||
| JAAM2 DIC score ≥ 3 | Positive | 14 (12.3%) | 16 (66.7%) | 0.000* |
| Negative | 100 (87.7%) | 8 (33.3%) | ||
| MPO (ng/ml) | Median (IQR) | 70.4 (58.5–79.0) | 109.0 (91.3–117.5) | 0.000≠ |
| Range | 36.4–107.8 | 79.8–124.8 | ||
| CIT-HIST-H3 (ng/ml) | Median (IQR) | 92.2 (60.0–141.4) | 269.9 (194.2–298.1) | 0.000≠ |
| Range | 18.2–376.9 | 81.3–341.3 | ||
P-value > 0.05: Non-significant; P-value < 0.05: Significant; P-value < 0.01: Highly significant.
*: Chi-square test; •: Independent t-test; ≠: Mann-Whitney test.